| abstract |
The present invention provides a bicyclic heterocyclic derivative (I) of the formula (I) which can be useful in therapy, more particularly as a bromodomain inhibitor, wherein R 1 , R 2 , R 3 , R 4 , L 1 , L 2 , Cy 1 , Cy 2 , n and dotted lines have the same meaning as described in the specification.) And pharmaceutically acceptable salts or pharmaceutically acceptable thereof The resulting stereoisomers (useful for the treatment and prevention of diseases or disorders), particularly their use in diseases or disorders related as bromodomain inhibitors, are provided. The invention also provides a process for preparing the compound and a pharmaceutical formulation comprising at least one bicyclic heterocyclic derivative of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient. |